跳至主要内容
临床试验/NCT03016858
NCT03016858Unknown3 期

Multicenter Randomized Controlled Clinical Trial of Thoracoscopic Bullectomy Surgery Under Nonintubated Intravenous Anesthesia With Spontaneous Ventilation

Guangzhou Institute of Respiratory Disease1 个研究点 分布在 1 个国家目标入组 320 人开始时间: 2016年12月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
发起方
入组人数
320
试验地点
1
主要终点
numbers of participants with postoperative respiratory and cardiovascular complications

研究概览

简要总结

With the development of video-assisted thoracoscopic surgery (VATS) techniques and technology for anesthesia control, non-intubated anesthesia with spontaneous ventilation has been widely applied in VATS. A multicenter randomized parallel controlled study was applied in this study to assess the efficacy and safety of thoracoscopic bullectomy surgery under intravenous anesthesia with spontaneous ventilation versus tracheal intubation general anesthesia.

详细描述

Intubated anesthesia with single lung mechanical ventilation (IASLV) is considered the standard of care in VATS. However, this type of anesthesia has been associated with several adverse effects, which can trigger complications and increase the overall surgical risk. In order to avoid intubated-anesthesia-related adverse effects, nonintubated strategies have been proposed in recent years.Encouraged by the satisfactory results with a preliminary experience of nonintubated VATS, the multicenter randomized parallel controlled study is established to comparatively analyze the outcome of patients undergoing either nonintubated intravenous anesthesia with spontaneous ventilation (NIIASV) or IASLV VATS thoracoscopic bullectomy surgery,especially in complication rate, safety during operation, muscle recovery after surgery, the difference the postoperative hospitalization time.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 50 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • volunteering to participate in clinical trials and having the ability of responsibility can be signed informed consent.
  • 16-50 years old
  • preoperative chest CT diagnosed with "localized lung bulla" and needing surgical treatment
  • Eastern Cooperative Oncology Group(ECOG) score standard ≤ 1
  • ASA(American Society of Anesthesiologists score) ≤ 2
  • Heart ejection fraction( EF)≥ 50%

排除标准

  • refusing to participate in clinical trials
  • A history of tuberculosis or other diseases could cause pleural adhesion or more pleural effusion
  • BMI ≥ 25 kg/m^2
  • other not suitable situations

研究组 & 干预措施

NIIASV

Experimental

undergoing Thoracoscopic Bullectomy Surgery under nonintubated intravenous anesthesia with spontaneous ventilation(NIIASV)

干预措施: Thoracoscopic Bullectomy Surgery (Procedure)

IASLV

Active Comparator

undergoing Thoracoscopic Bullectomy Surgery under intubated anesthesia with single-lung mechanical ventilation(IASLV)

干预措施: Thoracoscopic Bullectomy Surgery (Procedure)

结局指标

主要结局

numbers of participants with postoperative respiratory and cardiovascular complications

时间窗: from operation to discharging, an average of 1 week

The numbers of participants with postoperative respiratory and cardiovascular complications will be reported. The postoperative complications include postoperative respiratory complications(e.g., air leaks, lung infections, atelectasis, and bronchospasm and respiratory failure), postoperative cardiovascular complications(e.g., arrhythmias, myocardial infarction, cardiac failure) , intubated related complications(e.g., hoarseness, sore throat, and irritating cough), and other undefined complications

次要结局

  • numbers of participants with unstable vital signs, hypoxemia or hypercapnia intraoperatively(during the surgical operation, an average of 1 hour)
  • numbers of participants with anesthesia conversion intraoperatively in nonintubated group(during the surgical operation, an average of 1 hour)
  • numbers of participants with postoperative complications(from operation to discharging, an average of 1 week)

研究者

发起方
Guangzhou Institute of Respiratory Disease
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jun Liu

Professor

Guangzhou Institute of Respiratory Disease

研究点 (1)

Loading locations...

相似试验